• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性帕金森病中泛素羧基末端水解酶基因突变的低频性

Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease.

作者信息

Lincoln S, Vaughan J, Wood N, Baker M, Adamson J, Gwinn-Hardy K, Lynch T, Hardy J, Farrer M

机构信息

Mayo Clinic Jacksonville, FL 32224, USA.

出版信息

Neuroreport. 1999 Feb 5;10(2):427-9. doi: 10.1097/00001756-199902050-00040.

DOI:10.1097/00001756-199902050-00040
PMID:10203348
Abstract

A coding substitution (I93M) in the ubiquitin carboxy-terminal L1 (UCH-L1) gene has recently been identified in a German family with Parkinson's disease. We have sequenced the entire coding region of the gene in 11 families who have a pattern of disease consistent with autosomal dominant inheritance. We found a polymorphism (S18Y) in exon 3, two polymorphisms in the 5' non-coding region, upstream of the transcription start, and an insertion/deletion polymorphism in intron 4. The S18Y allele is present on approximately 20% of chromosomes in a Caucasian population. These changes are, therefore, unlikely to be pathogenic. We conclude that the I93M variant must either be a rare cause of disease or a harmless substitution whose occurrence in the family reflects a chance co-occurrence.

摘要

最近在一个患有帕金森病的德国家庭中发现泛素羧基末端L1(UCH-L1)基因存在编码替换(I93M)。我们对11个具有符合常染色体显性遗传疾病模式的家庭中的该基因整个编码区域进行了测序。我们在第3外显子中发现了一个多态性(S18Y)、转录起始上游5'非编码区域中的两个多态性以及第4内含子中的一个插入/缺失多态性。在高加索人群中,约20%的染色体上存在S18Y等位基因。因此,这些变化不太可能具有致病性。我们得出结论,I93M变异体要么是一种罕见的致病原因,要么是一种无害的替换,其在该家庭中的出现反映了一种偶然的同时发生。

相似文献

1
Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease.家族性帕金森病中泛素羧基末端水解酶基因突变的低频性
Neuroreport. 1999 Feb 5;10(2):427-9. doi: 10.1097/00001756-199902050-00040.
2
The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease.泛素羧基末端水解酶-L1基因S18Y多态性不能为特发性帕金森病提供保护作用。
Neurosci Lett. 2000 Oct 27;293(2):127-30. doi: 10.1016/s0304-3940(00)01510-x.
3
No genetic association of the ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism with familial Parkinson's disease.泛素羧基末端水解酶-L1基因S18Y多态性与家族性帕金森病无基因关联。
J Neural Transm (Vienna). 2001;108(8-9):979-84. doi: 10.1007/s007020170017.
4
Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease.帕金森病中泛素羧基末端水解酶L1基因的病例对照研究。
Neurology. 1999 Nov 10;53(8):1858-60. doi: 10.1212/wnl.53.8.1858.
5
Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients.德国帕金森病患者UCHL1基因的突变分析及关联研究。
Neuroreport. 2000 Jul 14;11(10):2079-82. doi: 10.1097/00001756-200007140-00004.
6
Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease.泛素羧基末端水解酶L1基因在亨廷顿舞蹈病中的突变分析及关联研究。
Neurosci Lett. 2002 Aug 2;328(1):1-4. doi: 10.1016/s0304-3940(02)00231-8.
7
ACT and UCH-L1 polymorphisms in Parkinson's disease and age of onset.帕金森病中的ACT和UCH-L1基因多态性与发病年龄
Mov Disord. 2002 Jul;17(4):767-71. doi: 10.1002/mds.10179.
8
Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants.帕金森病相关的人泛素羧基末端水解酶L1变体的结构和水解酶活性改变。
Biochem Biophys Res Commun. 2003 Apr 25;304(1):176-83. doi: 10.1016/s0006-291x(03)00555-2.
9
The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease.
Neurosci Lett. 1999 Jul 23;270(1):1-4. doi: 10.1016/s0304-3940(99)00465-6.
10
An Ile93Met substitution in the UCH-L1 gene is not a disease-causing mutation for idiopathic Parkinson's disease.UCH-L1基因中的Ile93Met替换不是特发性帕金森病的致病突变。
Chin Med J (Engl). 2003 Feb;116(2):312-3.

引用本文的文献

1
Loss of UCHL1 rescues the defects related to Parkinson's disease by suppressing glycolysis.UCHL1 的缺失通过抑制糖酵解挽救与帕金森病相关的缺陷。
Sci Adv. 2021 Jul 9;7(28). doi: 10.1126/sciadv.abg4574. Print 2021 Jul.
2
Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease.DNAJC13、UCHL1、HTRA2、GIGYF2 和 EIF4G1 与帕金森病的关联研究。
Neurobiol Aging. 2021 Apr;100:119.e7-119.e13. doi: 10.1016/j.neurobiolaging.2020.10.019. Epub 2020 Oct 31.
3
Long Non-coding RNAs Associated With Neurodegeneration-Linked Genes Are Reduced in Parkinson's Disease Patients.
与神经退行性变相关基因关联的长链非编码RNA在帕金森病患者中减少。
Front Cell Neurosci. 2019 Feb 22;13:58. doi: 10.3389/fncel.2019.00058. eCollection 2019.
4
Ubiquitin C-terminal Hydrolase L1 Regulates Lipid Raft-dependent Endocytosis.泛素羧基末端水解酶L1调节脂筏依赖性内吞作用。
Exp Neurobiol. 2018 Oct;27(5):377-386. doi: 10.5607/en.2018.27.5.377. Epub 2018 Oct 31.
5
Drosophila Ubiquitin C-Terminal Hydrolase Knockdown Model of Parkinson's Disease.果蝇泛素 C 端水解酶敲低帕金森病模型。
Sci Rep. 2018 Mar 13;8(1):4468. doi: 10.1038/s41598-018-22804-w.
6
Biochemical changes in the injured brain.受损大脑中的生化变化。
World J Biol Chem. 2017 Feb 26;8(1):21-31. doi: 10.4331/wjbc.v8.i1.21.
7
The Next Generation of Biomarker Research in Spinal Cord Injury.脊髓损伤生物标志物研究的下一代进展
Mol Neurobiol. 2017 Mar;54(2):1482-1499. doi: 10.1007/s12035-016-9757-x. Epub 2016 Feb 5.
8
Combination therapies: The next logical Step for the treatment of synucleinopathies?联合疗法:治疗突触核蛋白病的下一个合理步骤?
Mov Disord. 2016 Feb;31(2):225-34. doi: 10.1002/mds.26428. Epub 2015 Sep 21.
9
Mitochondria: A Therapeutic Target for Parkinson's Disease?线粒体:帕金森病的治疗靶点?
Int J Mol Sci. 2015 Sep 1;16(9):20704-30. doi: 10.3390/ijms160920704.
10
Association between ubiquitin carboxy-terminal hydrolase-L1 S18Y variant and risk of Parkinson's disease: the impact of ethnicity and onset age.泛素羧基末端水解酶-L1 S18Y变异体与帕金森病风险之间的关联:种族和发病年龄的影响。
Neurol Sci. 2015 Feb;36(2):179-88. doi: 10.1007/s10072-014-1987-y. Epub 2014 Nov 6.